An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer
A Multicentre, Retrospective, Observational Study to Analyse the Efficacy of High Dose Isofosfamide Administered Through Elastomer in Patients With Relapsed/ Refractory Osteosarcoma
Sponsor: Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
This observational or N/A phase trial investigates Osteosarcoma Recurrent and is currently completed. Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2022 — Jun 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Sep 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
May 2021 — Sep 2021 [monthly]
Recruiting
-
Mar 2021 — May 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
First recorded
Oct 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
For direct contact, visit the study record on ClinicalTrials.gov .